Prostate cancer Board decisions

The Board denied the Veteran's claim for service connection for prostate cancer as due to herbicide agent exposure, finding that there was no evidence of Vietnam service and thus not entitled to presumptive service connection.

The Veteran's claims for prostate cancer, metastatic bone cancer to include the pelvis, right scapula, and lateral right rib, and metastatic cancer of the lymph nodes are being remanded due to potential errors in dose estimates from the Department of Defense.

The Board has decided that the claim for service connection for the cause of death is remanded due to new evidence submitted by the appellant, which relates to an unestablished fact necessary to substantiate the claim. The Veteran's exposure to radiation at Manzano Base is also a relevant issue.

The Board denied the Veteran's claims for service connection for prostate cancer and dengue fever, finding that there was no evidence of a relationship between these conditions and his military service or exposure to herbicides.

The Board has denied service connection for ischemic heart disease and chloracne. The issues of service connection for an acquired psychiatric disorder (including PTSD and depression), prostate cancer, and diabetes mellitus are remanded due to the need for further verification of exposure and examination.

The Veteran's claim for service connection for prostate cancer and residuals was granted with an effective date of January 24, 2017. The Board found that the earliest date of claim was January 24, 2017, which is not earlier than this effective date.

The Veteran's heart condition and prostate cancer are granted service connection. The remaining issues, including back pain, respiratory disability, hypertension, GERD, and psychiatric disorder, are remanded for further development.

The Board has remanded the Veteran's claims for service connection for peptic ulcer disease with Barrett's esophagus, irritable colon syndrome, and prostate cancer due to lack of evidence establishing herbicide agent exposure in service.

The Veteran's claims for higher evaluations and service connection have been remanded by the Board. The VA is directed to obtain private treatment records, provide a medical opinion on the etiology of any diagnosed skin disorder, and readjudicate the claims.

The Veteran's service-connected disabilities have not rendered him unable to secure or follow a substantially gainful occupation, as his PTSD and prostate cancer do not prevent him from working.

The Board has determined that the reduction of the Veteran's disability rating for prostate cancer from 100% to noncompensable effective August 1, 2016 was proper. However, a VA examination is needed to determine if a compensable disability rating is warranted for prostate cancer residuals.

The Board denied the Veteran's claim for a combined total disability rating greater than 100 percent, finding that his service connected disabilities already warranted a 100% combined rating.

The Veteran's claim for an initial rating greater than 40 percent for prostate cancer from December 1, 2012, to November 15, 2018, was denied. The Veteran's claim for a TDIU due to service-connected bronchial asthma and prostate cancer from December 1, 2012, to November 15, 2018, was granted.

The Veteran's PTSD is currently rated at 50 percent, with symptoms including flattened affect, difficulty understanding complex commands, and impaired judgment. The effective date for this rating remains pending as the decision was made in August 2016.

The Board has remanded the case due to an inadequate medical opinion in a previous decision. The Veteran's claim for compensation under 38 U.S.C. § 1151 for residuals of prostate cancer prior to July 20, 2011 is now pending and will be reconsidered.

The Board has remanded the Veteran's claims for service connection for arteriosclerotic cardiovascular disease and prostate cancer due to exposure to Agent Orange while in service.

The Board has granted service connection for ureteral cell carcinoma of the ureter and bladder, chronic renal insufficiency, status post left total nephrectomy, and prostate cancer due to herbicide agent exposure. The conditions are presumed to be related to service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no evidence of radiation exposure and noting that there is no probative evidence establishing a link between the current prostate cancer and active service.

The Board has remanded the claims for hypertension, hypertensive nephrosclerosis (claimed as kidney failure), prostate cancer, and diabetes mellitus type II due to exposure to Camp Lejeune Contaminated Water, asbestos, jet fuel, and lead poisoning. The Veteran's records are incomplete and need to be obtained.

The Board has denied service connection for various conditions, including coronary artery disease with congestive heart failure, posttraumatic stress disorder, prostate cancer, bilateral hearing loss, and diabetes mellitus type II. Service connection was granted for tinnitus.